An underground market for unlicensed weight-loss drugs is being driven by social media fitness personalities and sellers on messaging platforms, according to recent findings.
Investigational Drug Gaining Traction Online
The experimental drug, which remains in research studies, is being promoted by online personalities for its supposed fat-burning effects. Viewers are urged to contact these profiles directly for supplier links, while also receiving discount codes.
Active Commerce on Messaging Platforms
Additionally, a robust market exists on Telegram, where groups with thousands of participants share comparison images, administration instructions and assertions of next-day UK delivery. Vendors market the substance there before directing buyers to other platforms for purchases.
Understanding Retatrutide
Retatrutide is an investigational injection developed by American pharmaceutical company Eli Lilly. The treatment affects three intestinal hormones – glucagon-like peptide-1, GIP and pancreatic hormone. Early trials suggest it could help patients reduce up to 25% of their body weight. Referred to as the “triple G”, the drug is being promoted online as the successor to Ozempic.
Healthcare Experts Express Worries
However, doctors and chemists have warned that the distribution of what remains an unlicensed drug in the United Kingdom is worrisome and could result in users injecting substances of unknown origin.
Some experts said the popularity for retatrutide could be linked to the increasing price of licensed weight loss products such as Mounjaro.
Regulatory Position and Implementation
Selling the unapproved drug on TikTok or messaging apps is prohibited in the UK, as it is an unapproved medication that cannot be marketed or distributed for human use under the British medical regulations.
Some influencers try to sidestep the rules by referring to the drug as a “research chemical” or citing it as “not for human consumption”. The substance is not a controlled drug, but promotion and distribution can still violate medicines, advertising, and consumer regulations, risking fines, prosecution or prison.
Service Reaction and Material Elimination
According to TikTok, the platform has taken down violative content and banned associated keywords and search suggestions. The organization stated it was committed to maintaining the platform secure and investing in enhancing compliance measures.
Online Marketplace Operations
Research also found groups with up to nine thousand members selling retatrutide using Telegram's built-in search feature, which operates like a public directory. Entering “retatrutide” instantly displays groups with numerous of members, filled with photos of slimming results, glowing reviews and step-by-step guides for mixing or injecting at residence.
Within moments of joining one community, a vendor posted contact information, where the majority of transactions occur. The vendor provided an guidebook and promised delivery within 48 hours. When asked whether the product was authentic, one seller responded: “You can’t be sure.” Another provided a photo of a alleged laboratory certificate. Not one asked about body mass, medical conditions or past usage.
Product Details and Costs
Within these groups, messages display black plastic parcels with postal service labels, stating to contain new batches. One message read: “It took eight of us to load them this morning.”
Buyers can select between powder vials, prepared at home with sterile water, or pre-filled pens typically sold at 160 pounds for 20 milligrams. When questioned how long a injector should last, sellers give contradictory responses varying between a few weeks to “depends on your body”.
Service Oversight and Safety Actions
A representative for Telegram stated it regularly moderated harmful material on its platform including material that encouraged the “misuse of controlled medications”. The company added that it eliminated “millions of pieces of harmful content each day”.
Healthcare Expert Warnings
“People are injecting substances they cannot confirm. Even if the science behind retatrutide is sound, these online products may not contain what they claim,” said Jason Murphy, the director of pharmacy at Chemist4U.
A medical professional of Asda Online Doctor linked the surge in interest to recent cost increases for approved weight-loss medications such as Mounjaro. “With costs rising, individuals are turning to online platforms. But counterfeit injections are extremely risky. You can’t be certain what’s contained or whether the environment they were made in was sterile,” she said.
Her staff has previously seen patients injured by personal administration from unverified sources. “We understand the frustration, but buying from messaging apps or communication platforms is gambling with your well-being,” said Wyllie. “These substances could be impure or improperly measured.”
Manufacturer Statement
A spokesperson from the pharmaceutical company said retatrutide was in phase 3 research studies and had not been evaluated or authorized by any government authority anywhere in the world. “Therefore at this time no one can sell [it] for personal consumption,” they explained, adding that any product “falsely representing itself as a company investigational substance not yet authorized … may expose users to possibly significant health risks”.
